AMGN - Amgen Inc

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.

52W High

$330.26

52W Low

$247.06

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.48

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

22.89

Forward P/E (<15 better)

12.95

EV/EBITDA (<8 favorable)

12.52

EV/Revenue (<3 favorable)

5.70

P/S (TTM) (<3 favorable)

4.32

P/B (<3 favorable)

20.29

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.21%

Institutions (25–75% balanced)

84.09%

Shares Outstanding

538,362,000

Float

536,994,000

Dividend Yield (2–6% sweet spot)

0.03%

Ex‑Dividend Date

2025-08-22

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

34,916,999,000

Gross Profit (TTM)

24,217,999,000

EPS (TTM)

12.23

Profit Margin (>10% good)

0.19%

Operating Margin (TTM) (higher better)

0.33%

ROE (TTM) (>15% strong)

0.99%

EPS YoY (Quarterly) (>10% good)

0.92

Revenue YoY (Quarterly) (>8% good)

0.09

Momentum

Bearish momentum

Value

-3.9376

-3.4890

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025